Inhibitory DGAT

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

SERRANO-WU MICHAEL H,KWAK YOUNG-SHIN,LIU WENMING

申请号：

PL11158224

公开号：

PL2402319T3

申请日:

2007.03.28

申请国别(地区):

PL

年份:

2018

代理人:

摘要：

The present invention provides new organic compounds of the following formula: €ƒ€ƒ€ƒ€ƒ€ƒ€ƒ€ƒ€ƒA-L1-B-C-D-L2-E wherein A, L1, B, C, D, L2 and E are as defined in the description of the invention, that are useful for treating or preventing conditions or disorders associated with DGAT1 activity, particularly type 2 diabetes, and pharmaceutical compositions comprising such compounds.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/